Abstract:Bone Morphogenetic Proteins (BMPs) and other members of TGFβ superfamily regulate cell growth and differentiation. Abrogation of cellular responses to BMP/TGFβ is associated with human diseases such as cancer, cardiovascular, autoimmune and skeletal diseases. One of the most critical events in activation of BMP signal transduction pathway is the phosphorylation of transcription factor Smad1/5/8 (collective term for Smad1, Smad5 and Smad8) by BMP receptors. While phosphorylated Smad1/5/8 directly activate the BMP-induced gene transcription in the nucleus, protein phosphatases are anticipated to dephosphorylate phospho-Smad1/5/8 and consequently terminate BMP signaling. The identity of the long sought-after phosphatase has been one of the major unanswered questions in BMP/TGFβ biology. Objective: (1) To characterize how PPM1H physically interacts with and functionally dephosphorylate BMP-specific Smads, and (2) to investigate the functions of PPM1H in BMP-induced gene expression and osteoblast differentiation. Methods: We first built a library consisting of the entire set of protein phosphatases encoded by the human genome and then undertook a genome-wide screen for Smad phosphatases. BMP-induced Smad phosphorylation was analyzed using immunological methods such as immunoprecipitation, western blotting and immunofluorescence. Effects of PPM1H overexpression and knockdown on the level of Smad phosphorylation were determined by anti-phospho-Smad1 Western blotting. Real-time PCR, transcriptional analyses of BMP target genes and alkaline phosphatase assays were carried out to determine the functions of PPM1H in regulating BMP responses and osteoblast differentiation. Results: To identify the Smad phosphatases, we first built a library consisting of the entire set of protein phosphatases encoded by the human genome and then undertook a genome-wide screen. By using combined methods of functional genomics and biochemistry, we discovered that PPM1H represents a novel cytoplasm-localized Smad1/5/8-specific phosphatase. The effects of PPM1H on controlling the level of phosphorylated Smad1/5/8 (P-Smad1/5/8) were analyzed by immunological methods, e.g. immunofluorescence and western blotting, using a phospho-specific antibody against P-Smad1/5/8. PPM1H clearly dephosphorylated P-Smad1/5/8 in vivo and in vitro. In vitro binding, immunoprecipitation, and bimolecular fluorescence complementation assays demonstrated that PPM1H and Smad1 directly interact with each other in the cytoplasm. Consequently, ectopic expression of PPM1H in cells abolished BMP-induced gene expression as measured by real-time PCR and transcriptional reporter assays, and loss of PPM1H activity (site mutagenesis) or expression (RNA interference) greatly enhanced BMP signaling and osteoblast differentiation. Conclusion: PPM1H acts as a gatekeeper to prevent excessive BMP signal transduction through dephosphorylation and subsequent nuclear exclusion of Smad1/5/8. Our results not only gain insights into the important role of BMP signaling in human growth and development, but also are pertinent towards novel therapeutic approaches for the prevention and treatment of human diseases.

The Lysine Methyltransferase SMYD2 Methylates the Kinase Domain of Type II Receptor BMPR2 and Stimulates Bone Morphogenetic Protein Signaling

Arginine Methylation of R81 in Smad6 Confines BMP-induced Smad1 Signaling

Histone Methyltransferase SMYD2: Ubiquitous Regulator of Disease

Nuclear Export of Smads by RanBP3L Regulates Bone Morphogenetic Protein Signaling and Mesenchymal Stem Cell Differentiation.

Activation of c-Jun NH2-terminal kinase 1 increases cellular responsiveness to BMP-2 and decreases binding of inhibitory Smad6 to the type 1 BMP receptor

Role of histone methyltransferase KMT2D in BMSC osteogenesis via AKT signaling

C-terminal Domain (CTD) Small Phosphatase-like 2 Modulates the Canonical Bone Morphogenetic Protein (BMP) Signaling and Mesenchymal Differentiation Via Smad Dephosphorylation*

KDM5A controls bone morphogenic protein 2-induced osteogenic differentiation of bone mesenchymal stem cells during osteoporosis

Tet2 Activity is Modulated by Sirt1-Mediated Protein Deacetylation: A Potential Therapeutic Target in Myelodysplastic Syndrome

SMYD5 Catalyzes Histone H3 Lysine 36 Trimethylation at Promoters

Bone Morphogenetic Protein 2 Regulates Cell-Cell Communication by Down-Regulating Connexin43 Expression in Luteinized Human Granulosa Cells

SMAD1/5 Mediates Bone Morphogenetic Protein 2-Induced Up-Regulation of BAMBI Expression in Human Granulosa-Lutein Cells.

Methylation of the chromatin modifier KMT2D by SMYD2 contributes to therapeutic response in hormone-dependent breast cancer

Bone Morphogenetic Protein Receptor Signal Transduction in Human Disease

A variant in SMOC2, inhibiting BMP signaling by competitively binding to BMPR1B, causes multiple epiphyseal dysplasia

Critical roles of SMYD2 lysine methyltransferase in mediating renal fibroblast activation and kidney fibrosis

SMYD2‐mediated TRAF2 methylation promotes the NF‐κB signaling pathways in inflammatory diseases

N-linked glycosylation of the bone morphogenetic protein receptor type 2 (BMPR2) enhances ligand binding

Methylation of the retinoblastoma tumor suppressor by SMYD2

Structural Basis for Substrate Preference of SMYD3, a SET Domain-containing Protein Lysine Methyltransferase*

Novel Phosphatase PPM1H Controls BMP Signaling and Osteoblast Differentiation